A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
Clinical trial NCT05682638 · UNKNOWN
Trial details
- NCT number
- NCT05682638
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2024-12-01
- Enrollment
- 34000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.